Professional
Added to YB: 2025-10-30
Pitch date: 2025-09-30
BSX [bullish]
Boston Scientific Corporation
-22.7%
current return
Author Info
No bio for this author
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$113.1B
Pitch Price
$97.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.17
P/E
39.32
EV/Sales
6.18
Sector
Health Care Equipment and Supplies
Category
growth
Polen Global Growth New Position: Boston Scientific Corporation
BSX (new position): Acquired 2% position in medical device leader. Growth accelerating on two catalysts: Farapulse PFA platform (less invasive atrial fib treatment likely to become standard of care) & dominant Watchman atrial appendage platform. Low double-digit revenue growth + margin expansion = mid-teens earnings growth potential over 3-5 years.
Read full article (1 min)